(Total Views: 528)
Posted On: 05/13/2020 8:24:33 AM
Post# of 154091
I posted this one yesterday
Ibalizumab
Ibalizumab is a humanized monoclonal antibody that targets a human protein rather than attacking the virus directly. It binds to the CD4 receptor on the surface of T-cells and prevents the virus from entering them.
Ibalizumab (TMB-355) has been in development for more than a decade, currently by TaiMed Biologics and previously by Tanox (where it was known a
Ibalizumab
Ibalizumab is a humanized monoclonal antibody that targets a human protein rather than attacking the virus directly. It binds to the CD4 receptor on the surface of T-cells and prevents the virus from entering them.
Ibalizumab (TMB-355) has been in development for more than a decade, currently by TaiMed Biologics and previously by Tanox (where it was known a
(0)
(0)
